A detailed history of Perpetual LTD transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Perpetual LTD holds 3,632,677 shares of ADMA stock, worth $58.4 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
3,632,677
Holding current value
$58.4 Million
% of portfolio
0.73%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

BUY
$15.62 - $22.62 $56.7 Million - $82.2 Million
3,632,677 New
3,632,677 $62.3 Billion

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.16B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Perpetual LTD Portfolio

Follow Perpetual LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perpetual LTD, based on Form 13F filings with the SEC.

News

Stay updated on Perpetual LTD with notifications on news.